Week in Brief
President Trump Delivers His First State of the Union Address to Congress.
Dr. Brenda Fitzgerald, Director of the Centers for Disease Control and Prevention, Resigns After an Investigation Reveals She Purchased Stock in a Tobacco Company While Serving as Director of the CDC.
January 30, 2018
Small Business Health Plans: The Senate HELP Subcommittee on Primary Health and Retirement Security Holds a Roundtable on Small Business Health Plans. HELP Committee Chairman Lamar Alexander (R-TN) Issues an Opening Statement.
Drug Compounding: The House Energy and Commerce Committee Holds a Hearing Entitled, “Examining Implementation of the Compounding Quality Act.” Committee Chairman Greg Walden (R-OR), Health Subcommittee Chairman Michael Burgess (R-TX), and Representative Fred Upton (R-MI) Issue Opening Statements.
Department of Health and Human Services
January 30, 2018
Medicare, Medicaid, and CHIP: CMS Announces an Extension of Temporary Moratoria on Part B Non-Emergency Ground Ambulance Supplier and Home Health Agency Enrollment in Designated Locations.
Opioid Crisis: FDA Commissioner Scott Gottlieb, M.D., Releases Statement on Steps to Address Addiction, Abuse, and Overdose Related to Opioid Products.
Secretary Azar Responds to SOTU: HHS Secretary Alex Azar Issues Statement in Response to President Trump’s SOTU Address.
February 1, 2018
Medicare Advantage & Part D: CMS Proposes Changes to Medicare Advantage and Part D Payment and Policy to Provide New Benefits and Steps to Battle the Opioid Crisis.
House Ways and Means Committee
Hearing on the Opioid Crisis: Removing Barriers to Prevent and Treat Opioid Abuse and Dependence in Medicare
• February 6, 2018 | 3:00p.m.
Senate HELP Committee
The Opioid Crisis: Impact on Children and Families
• February 8, 2018|10:00a.m.
430 Dirksen Senate Office Building
House Energy and Commerce Committee
HHS Secretary Alex Azar To Testify Before #Subhealth
• February 15, 2018
For more information about this issue of Power Play: Washington Week in Review or more legislative and regulatory updates, contact the Powers Pyles Sutter & Verville Government Relations and Public Policy group at (202) 466-6550.